New drug formulations tested in healthy volunteers
NCT ID NCT06911567
First seen Jan 19, 2026 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study tested different versions of the drug TEV-56286 (emrusolmin) in 47 healthy adults to see how well the body absorbs each form. Participants took a single dose of either a new formulation or a reference capsule, and researchers measured drug levels in the blood. The goal was to compare the formulations and check for any safety issues over about 70 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Teva Investigational Site 12141
Miramar, Florida, 33025, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Emrusolmin (TEV-56286)
What this could lead to
If successful, this could help determine the best way to deliver emrusolmin in future studies, potentially leading to better treatments for conditions it targets.
What could go wrong
This is an early-stage trial in healthy volunteers, not patients. It only measures drug levels and short-term safety, so it cannot predict if the drug will work for any disease.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.